Frank, Rimerman Advisors LLC Repligen Corp Transaction History

Frank, Rimerman Advisors LLC

  • $1.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 07, 2023
SELL
$140.68 - $188.02 $300,773 - $401,986
-2,138 Closed
0 $0
Q4 2021

Sep 07, 2023
BUY
$247.59 - $304.47 $95,569 - $117,525
386 Added 22.03%
2,138 $566 Million
Q3 2021

Sep 07, 2023
BUY
$194.77 - $324.21 $341,237 - $568,015
1,752 New
1,752 $506 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.99B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email